Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients

Yi Chen,Ping Li,Yibo Ding,Miao Liu,Leijie Liu,Bo Yi,Ting Wu,Hongjun Dong,Xuying Lao,Keqing Ding,Haibo Wang,Dongliang Zhang,Xiaojie Tan,Zhongfa Wang,Guozhang Xu,Guangwen Cao
DOI: https://doi.org/10.1016/j.jiph.2021.05.003
IF: 7.537
2021-07-01
Journal of Infection and Public Health
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pandemic. However, data concerning the epidemiological features, viral shedding, and antibody dynamics between asymptomatic SARS-CoV-2 carriers and COVID-19 patients remain controversial.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We enrolled 193 SARS-CoV-2 infected subjects in Ningbo and Zhoushan, Zhejiang, China, from January 21 to March 6, 2020. All subjects were followed up to monitor the dynamics of serum antibody immunoglobulin M (IgM) and IgG against SARS-CoV-2 using colloidal gold-labeled and enzyme-linked immunosorbent assays.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of those, 31 were asymptomatic SARS-CoV-2 carriers, 149 symptomatic COVID-19 patients, and 14 presymptomatic COVID-19 patients. Compared to symptomatic COVID-19 patients, asymptomatic carriers were younger and had higher levels of white blood cell and lymphocyte, lower level of C-reactive protein, and shorter viral shedding duration. Conversion of IgM from positive to negative was shorter in asymptomatic carriers than in COVID-19 patients (7.5 vs. 25.5 days, <em>P</em> = 0.030). The proportion of those persistently seropositive for IgG against SARS-CoV-2 was higher in COVID-19 patients than in asymptomatic carriers (66.1% vs. 33.3%, <em>P</em> = 0.037). Viral load was higher in symptomatic patients than presymptomatic patients (<em>P</em> = 0.003) and asymptomatic carriers (<em>P</em> = 0.004). Viral shedding duration was longer in presymptomatic COVID-19 patients than in asymptomatic carriers (48.0 vs. 24.0 days, <em>P</em> = 0.002). Asymptomatic carriers acquired infection more from intra-familial transmission than did COVID-19 patients (89.0% vs. 61.0%, <em>P</em> = 0.028). In 4 familial clusters of SARS-CoV-2 infection, asymptomatic carriers were mainly children and young adults while severe COVID-19 was mainly found in family members older than 60 years with comorbidities.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Asymptomatic carriers might have a higher antiviral immunity to clear SARS-CoV-2 than symptomatic COVID-19 patients and this antiviral immunity should be contributable to innate and adaptive cellular immunity rather than humoral immunity. The severity of COVID-19 is associated with older age and comorbidities in familial clustering cases.</p>
infectious diseases,public, environmental & occupational health
What problem does this paper attempt to address?